|

Efruxifermin Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 3: 1

Top Sponsors

  • Akero Therapeutics, Inc1

Indications

  • Liver Disease1
  • MASH - Metabolic Dysfunction-Associated Steatohepatitis1
  • NASH - Nonalcoholic Steatohepatitis1

Birmingham, Alabama1 trial

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Akero Clinical Study Site

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.